Tyrosine kinase inhibitors and hypothyroidism – an intriguing link
Purpose: Along with increased cancer incidence, there is also an increased use of targeted cancer therapy. One of the most potent classes of targeted therapy drugs are tyrosine kinase inhibitors (TKIs). Several new TKIs have become available in clinical practice after the correlation of sunitinib an...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
VBZ
2016-06-01
|
| Series: | Endocrine Oncology and Metabolism |
| Subjects: | |
| Online Access: | http://eom.hdeo.eu/wp-content/uploads/2016/07/vol2-iss2-3Kust.pdf |